AJOONINSEAjooni Biotech LimitedLowNeutral
Announced Fri, 29 Aug · 17:23 IST

Ajooni Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2025

Board & Shareholder Meetings View source PDF

AJOONI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ajooni Biotech has called its 15th AGM on Monday, September 29, 2025, at 11:00 AM through video conferencing. The agenda includes routine items like adopting FY25 audited financial statements and re-appointing Mr. Partek Singh as a director (retiring by rotation). Shareholders will also vote on several related-party transactions (RPTs) with promoter-group entities — Healthy Biosciences (up to Rs 6 crore/year), Punjab Biotechnology Park (Rs 7 crore/year), Khanna Solvex (Rs 5.5 crore/year), Revive Aesthetics (Rs 50 lakh/year), and Gilbert Kasauli (Rs 40 lakh/year) — each for a 3-year period from FY26 to FY28. Other key proposals include re-appointing Mr. Jasjot Singh as Managing Director (remuneration raised to Rs 4 lakh/month) and Mr. Gursimran Singh as Whole-Time Director (Rs 2 lakh/month), approving remuneration for the MD's father (Rs 5 lakh/month), and authorizing loans, guarantees, or investments up to Rs 55 crore under Sections 185 and 186 of the Companies Act.

Likely market impact

Routine AGM notice, but shareholders should review the RPT and director remuneration proposals carefully — the RPT limits are sizable relative to the company's turnover and involve promoter-linked entities, and executive pay is being increased. Approval is needed for these resolutions to take effect, and a vote against could block them.